NCT02022163
- Conditions
- Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
- Locations
-
- Canadian Science Centre for Human and Animal Health Winnipeg, Manitoba, Canada
Clinical trial condition
RNA Virus Infections
Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.
81 public trials
4 recruiting studies
RNA Virus Infections trial results
NCT01838590
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +17 more
- Locations
-
- Al Mansurah, Egypt
- Cairo, Egypt
NCT01587131
- Conditions
- Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
- Locations
-
- MS Building Health Sciences Centre Winnipeg, Manitoba, Canada
NCT01641094
- Conditions
- Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +26 more
- Locations
-
- Reinier de Graaf Ziekenhuis Delft, South Holland, Netherlands
- Erasmus Medical Center Rotterdam, Netherlands
NCT01808248
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +17 more
- Locations
-
- Alamo Medical Research San Antonio, Texas, United States
NCT01431768
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Taringa 7 Day Medical Practice Brisbane, Queensland, Australia
- Capalaba Medical Centre Brisbane, Queensland, Australia
NCT01680094
- Conditions
- Blood-Borne Infections, Communicable Diseases, Disease Attributes, +15 more
- Locations
-
- Department of Infectious Diseases, Aarhus University Hospital Aarhus, Denmark
NCT01244867
- Conditions
- Infections, RNA Virus Infections, Respiratory Tract Diseases, +2 more
- Locations
-
- Kendle Early Stage Toronto, Ontario, Canada
NCT00593151
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
- Locations
-
- Henry Ford Hospital Detroit, Michigan, United States
- Methodist Dallas Medical Center Dallas, Texas, United States
- Alamo Medical Research San Antonio, Texas, United States
- Inova Center for Liver Diseases Annandale, Virginia, United States
Completed
Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study
NCT01251133
- Conditions
- Communicable Diseases, Disease Attributes, Infections, +9 more
- Locations
-
- Korea University Ansan Hospital Ansan, Gyeonggi-do, South Korea